Clinical Trials Sponsored by HistoGeneX

Total 7 results

Histogen

Unknown

Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss

Alopecia

United States
Histogen

Completed

Emricasan, an Oral Caspase Inhibitor, in Subjects With NASH Cirrhosis and Severe Portal Hypertension (ENCORE-PH)

Cirrhosis | Portal Hypertension | Non-alcoholic Steatohepatitis

United States, Germany, Spain
Histogen

Terminated

Safety and Tolerability of Emricasan in Symptomatic Outpatients Diagnosed With Mild-COVID-19

Covid19

United States
Histogen

Completed

Safety and Efficacy of HST 001 in Male Pattern Hair Loss

Male Pattern Hair Loss

United States
Histogen
Gleneagles CRC Pte Ltd.

Unknown

Safety and Efficacy of Hair Stimulating Complex (HSC) on Hair Growth in Males With Androgenetic Alopecia (HSC Phase I/II)

Androgenetic Alopecia

Philippines
Histogen
United States Department of Defense

Terminated

Human ECM Implanted Within Microfracture Interstices & the Cartilage Defect in the Knee to Regenerate Hyaline Cartilage (hECM;HST003)

Cartilage Damage | Articular Cartilage Disorder of Knee | Microfractures

United States
Universitaire Ziekenhuizen KU Leuven
KU Leuven; Hospital Clinic of Barcelona; MDx Health; Biomedical Research Foundation... and other collaborators

Not yet recruiting

Prospective Collection of Samples for Urothelial Cancer of Bladder (ProCSUCaB)

Bladder Cancer

3

Subscribe